Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Convertible Debt (2009 - 2011)

Updated

Abeona Therapeutics (ABEO) reported Convertible Debt of $2.75 million for Q2 2011, compared with $200,000 a year earlier.

Analysis

Abeona Therapeutics (ABEO) Convertible Debt (2009 - 2011) Analysis & Trends

Dating back to Q1 2009, Abeona Therapeutics' Convertible Debt record includes 6 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 2.75 Mn
Mar 31, 2011 200,000.00
Jun 30, 2010 200,000.00
Mar 31, 2010 200,000.00
Jun 30, 2009 200,000.00
Mar 31, 2009 200,000.00
API Access

Abeona Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=ABEO&period=max&api_key=YOUR_API_KEY